Abstract
Gadolinium‐Based Contrast Agents (GBCAs) for MRI: A Benefit–Risk Balance Analysis from a Chemical, Biomedical, and Environmental Point of View
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have